A Single-centre, Open-label, Non-controlled, Exploratory Safety and Efficacy Clinical Trial of GT08 in Volunteers and Patients Who Are Infected With Helicobacter Pylori.

Trial Profile

A Single-centre, Open-label, Non-controlled, Exploratory Safety and Efficacy Clinical Trial of GT08 in Volunteers and Patients Who Are Infected With Helicobacter Pylori.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 30 May 2014

At a glance

  • Drugs GT 08 (Primary)
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Sponsors Synergy Pharmaceuticals Inc
  • Most Recent Events

    • 01 Apr 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 09 Sep 2010 Actual initiation date added to 1 May 2010 as reported by ClinicalTrials.gov.
    • 09 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top